Basf Se (OTCMKTS:BASFY – Get Free Report) has been assigned an average recommendation of “Hold” from the seven ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have given a buy recommendation to the company.
A number of analysts recently weighed in on BASFY shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Basf in a report on Friday, March 7th. JPMorgan Chase & Co. downgraded Basf from a “neutral” rating to an “underweight” rating in a research report on Thursday, March 27th. Finally, Berenberg Bank lowered Basf from a “buy” rating to a “hold” rating in a research note on Tuesday, February 18th.
Read Our Latest Stock Report on Basf
Basf Trading Down 2.8 %
Basf (OTCMKTS:BASFY – Get Free Report) last posted its earnings results on Friday, May 2nd. The basic materials company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.38 by $0.03. The business had revenue of $18.31 billion for the quarter, compared to the consensus estimate of $17.34 billion. Basf had a net margin of 0.78% and a return on equity of 6.63%. As a group, sell-side analysts predict that Basf will post 0.83 EPS for the current fiscal year.
Basf Cuts Dividend
The firm also recently disclosed a dividend, which will be paid on Monday, May 19th. Stockholders of record on Wednesday, May 7th will be given a $0.4322 dividend. This represents a dividend yield of 3.38%. The ex-dividend date of this dividend is Tuesday, May 6th. Basf’s dividend payout ratio (DPR) is presently 186.96%.
Basf Company Profile
BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems comprising isocyanates, polyamides, and inorganic basic products, as well as specialties for plastics and plastics processing industries.
See Also
- Five stocks we like better than Basf
- How to Invest in Biotech Stocks
- 3 Mid-Cap Medical Stocks Outperforming the Market
- With Risk Tolerance, One Size Does Not Fit All
- The Top-Ranked Insider Buys From April by Market Cap
- What Are Dividend Contenders? Investing in Dividend Contenders
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.